Enterovirus a71 vaccines

Mei Ling Li*, Shin Ru Shih, Blanton S. Tolbert, Gary Brewer

*此作品的通信作者

研究成果: 期刊稿件文獻綜述同行評審

47 引文 斯高帕斯(Scopus)

摘要

Enterovirus A71 (EV-A71) is a major causative agent of hand, foot, and mouth disease (HFMD) and herpangina. Moreover, EV-A71 infection can lead to neurological complications and death. Vaccination is the most efficient way to control virus infection. There are currently three inactivated, whole EV-A71 vaccines licensed by the China NMPA (National Medical Products Administration). Several other types of vaccines, such as virus-like particles and recombinant VP1 (capsid protein), are also under development. In this review, we discuss recent advances in the development of EV-A71 vaccines.

原文英語
文章編號199
頁(從 - 到)1-10
頁數10
期刊Vaccines
9
發行號3
DOIs
出版狀態已出版 - 2021

文獻附註

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

指紋

深入研究「Enterovirus a71 vaccines」主題。共同形成了獨特的指紋。

引用此